The weekly litigation news digest is live. Subscribe now

IP Verse

Amerigen Pharmaceuticals competitive analysis

Loading summary...

Latest PTAB cases involving Amerigen Pharmaceuticals

Discover the latest PTAB cases involving Amerigen Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 16, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Amerigen Pharmaceuticals

IPR2017-00665Jan 13, 2017AMERIGEN PHARMACEUTICALSSHIRETerminated-Settled
IPR2016-01665Aug 22, 2016AMERIGEN PHARMACEUTICALSUCB PHARMAFinal Written Decision
IPR2016-00286Dec 4, 2015AMERIGEN PHARMACEUTICALSJANSSEN ONCOLOGYFinal Written Decision
IPR2015-02009Oct 1, 2015AMERIGEN PHARMACEUTICALSSHIREFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Amerigen Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMERIGEN PHARMACEUTICALS - - 4 -
JANSSEN ONCOLOGY - 22 - 5
SHIRE - - 14
UCB PHARMA - 12 - 8